 |
Dr. Larry W. Kwak received his MD and PhD in tumor
cell biology from Northwestern University Medical School.
After completing clinical training in internal medicine
and medical oncology at Stanford University, he was recruited
to the Biological Response Modifiers Program of the National
Cancer Institute in 1992. In 1996, he was appointed head
of the vaccine biology section at the National Institutes
of Health (NIH), then was recruited to M. D. Anderson
Cancer Center in 2004, where is he currently the Chairman
of the department of lymphoma and myeloma, as well as
the Associate Director of the Center for Cancer Immunology
Research. Dr. Kwak is also the incumbent of the Moshe
Talpaz Endowed Chair in Immunology at M. D. Anderson Cancer
Center. Dr. Kwak has served on the program committees
for the American Society of Hematology, the American Society
of Clinical Oncology (ASCO), and the NIH Experimental
Immunology Study Section. He is also a past recipient
of the ASCO Young Investigator Award. He has served on
the editorial board of the scientific journal Blood
and on the scientific advisory board of the Multiple
Myeloma Research Foundation.
Dr. Kwak's translational scientific and clinical interests
span tumor immunology, cancer vaccines, adoptive T-cell
immunotherapy, and clinical management of lymphomas and
myelomas. He has pioneered use of patient-specific vaccines
as treatment against human lymphomas and has served as
principal investigator of a multicenter Phase 3 randomized
clinical trial of lymphoma vaccination.
He is frequently invited to speak at national and international
scientific meetings. He has published in journals such
as Science, Nature Medicine, New
England Journal of Medicine and The Lancet.
 Back to Leadership
|
